TNI Logo


Provider conducting research


Healthcare Innovations Institute
Our research mission at the Healthcare Innovations Institute, an affiliate of The Neurology Institute, is to provide state of the art medical care and opportunities for patients to participate in clinical trials. Here our physicians are educated and informed on new drugs and devices, from pharmaceuticals to biotechnology, to use better strategies with our medical treatments for patients. In addition, our multi-lingual staff are able to explain the clinical trials thoroughly to our patients and answer any questions they may have.
Our physicians and nurse practitioners involved with research are on staff at Broward Health North, Coral Springs Medical Center, North West Medical Center, University Hospital and Kindred Hospital Hollywood and Fort Lauderdale. Daily, we have been successful in enrolling for all clinical trials offered.
Our facility includes: - Exam Rooms
- IV Infusion Services - Wifi Web - Ex & Video Conferences - Off Site Temperature Storage Facility
- Designated Laboratory & Centrifuges - Temperature Controlled Drug Freezer ( -20 °C ) & Refrigerators (2-8 °C) - Double Locked Medication Room- Dry Ice

Accessibility: - Free Parking / Transit Bus Line - Senior Shuttle Stops in front of the building - Miami & Fort Lauderdale International Airports
- Emergency Room 200 Ft from the Research Facility with 911 Paramedics.


Parkinson's Disease
Parkinson's Disease
We are proud to offer patients ground breaking therapeutic options at multiple stages of the disease. We are actively enrolling patients in Phase II, Phase III and Phase IV clinical trials for Parkinson's Disease. This provides us revolutionary alternatives to conventional regimens.
Multiple Sclerosis (MS)
Multiple Sclerosis (MS)
We participate in several clinical trials for MS. We understand this diseases multiple forms and presentations. We continue to pursue additional clinical trials to offer promising results. We also have a non-interventional trial involved with gathering data to better characterize the natural history of MS and to evaluate the effectiveness and safety of treatment medications for MS.
Traumatic Brain Injury (TBI)
At this time, we are able to provide cutting edge treatment options for patients suffering from traumatic brain injuries. We are actively enrolling patients in a clinical trial investigating the efficacy of a medication to treat neurobehavioral disinhibition (including aggression, agitation, and irritability) in patients with traumatic brain injury. We provide support with both neuropsychological testing and cognitive behavioral therapy.
Multiple Sclerosis (MS)
Trigeminal Neuralgia
For patients suffering from this debilitating disorder, not only are we providing expertise with traditional medications, we are excited to offer a clinical trial evaluating the efficacy of a medication to treat patients with Trigeminal Neuralgia.
Alzheimer's Disease
Alzheimer's Disease
As we continue to serve a large patient population with this progressive neurodegenerative disorder, with the support of clinical neuropsychologists and clinical psychologists, we understand the need for cutting edge research to combat this disease. We offer multiple clinical trials for Alzheimer's Disease. This includes ICARE AD Research Project. We are also excited to offer patients the opportunity to enroll in trial addressing Dementia with agitation. As medical providers we continue to acknowledge the need to minimize the caregiver burden.
Mood Disorders/Depression
Mood Disorders/Depression
Offering Pilot Study with supervised home based transcranial direct current stimulation for major depressive disorders (MDD). Enrolling for other mood disorders with a variety of therapeutic options.
Multiple Sclerosis (MS)
CIDP (Chronic Inflammatory Demyelinating Polyneuropathy)

 Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Subcutaneously Administered Efgartigimod with rHuPH20 in Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy 
Investigating and analyzing cancer genetics for strategic targeting of genes and optimal Cancer Prevention.
Other Specialty Trials
Other Specialty Trials
Our site is also conducting several multiple specialty trials investigating interventional medication for a variety of neurological disorders.
Other Specialty Trials
Myasthenia Gravis
Now open for enrollment in  

Phase 3B, Randomized, Open-label, Parallel-Group Trial to Evaluate Different Dosing Regimens of Intravenous Efgartigimod to Maximize and Maintain Clinical Benefit in Patients With Generalized Myasthenia Gravis
Other Specialty Trials
Alzheimer's Dementia
If you are a caregiver for someone with Alzheimer’s dementia, you may be familiar with the agitated behaviors that many people with this condition experience.
Examples of some easily identifiable agitated behaviors are:
• Restlessness
• Pacing/aimless wandering
• Screaming
• Kicking
• Shouting
• Hitting others or self
• Throwing things
• Pushing people
• Resistiveness
• Hurting self or others
• Constant unwarranted requests for attention or help
• Tearing things or destroying property
To be eligible for this study, a potential participant must:
Be between the ages of 50 and 90
Have a diagnosis of probable Alzheimer’s disease
Have moderate-to-severe agitation that interferes with their daily life

Other Specialty Trials
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
These are some of the requirements to participate in the study:
• Be at least 18 years old
• Be diagnosed with probable or definite CIDP, your study physician will determine this diagnosis
• Not be pregnant or nursing
• Be willing to travel to the study location on a regular basis
• Meet other criteria that the study staff will discuss

Other Specialty Trials
Multiple Sclerosis; Primary Progressive
• To be eligible for this study, you must:
• Be between 18 and 65 years old
• Be diagnosed with PPMS or SPMS
• Have not experienced worsening of MS symptoms within the past 2 years

This is a partial list of study requirements. The study doctor will review the full requirements for this study with you.

Other Specialty Trials
Multiple Sclerosis; Relapsing (RMS)
Study Period:
The trial consists of screening, a double-blind treatment period up to a maximum of 72 weeks, or shorter if certain MS-related activity occurs.

• You may be eligible to participate in the ENSURE study if you:
• Are between 18 and 55 years old
• Are diagnosed with RMS
• Have a recent history of active disease, meaning at least 2 relapses in the last 2 years or 1 relapse in the last year


Better yet, see us in person! Contact us!
Come to our Coral Springs or Tamarac locationsHealthcare Innovations Institute THE NEUROLOGY INSTITUTE 5441 N UNIVERSITY DRIVE, SUITE 101
Coral Springs, FL 33067